Plasma total cholesterol (TC) (8), triglyceride (TG) (9), low-density lipoprotein cholesterol (LDL-C) (10), apolipoprotein (Apo) B (11), high-density lipoprotein cholesterol (HDL-C) (12), ApoA1 and the ApoA1/ApoB ratio (13) are traditionally monitored as predictors of dyslipidemia and also the main target for therapeutic intervention, by regulating blood lipid control (14). Here, APOA1 is linked to metabolic syndrome.